These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6162797)

  • 1. Serological characterization of previously unknown H-2 molecules identified in the products of the Kd and Dk region.
    Iványi D; Démant P
    Immunogenetics; 1981; 12(3-4):397-408. PubMed ID: 6162797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. II. B10.D2(M504) (H-2dm1) mutant fails to express one of the two H-2.4-, 28 + Dd region molecules.
    Iványi D; Démant P
    Immunogenetics; 1982; 15(5):467-76. PubMed ID: 6980826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One (H-2D2b) of the three Db region-controlled molecules (H-2D1b, H-2D2b, H-2Lb) is not detected in bm13 mutant.
    Iványi D; Démant P
    J Immunol; 1983 Sep; 131(3):1080-4. PubMed ID: 6604086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2L: demonstration of four new allelic products and independence of H-2D and H-2L molecules.
    Iványi D; Snoek M; Démant P
    Tissue Antigens; 1979 Sep; 14(3):233-50. PubMed ID: 93315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further molecular complexities of H-2 K- and D-region antigens.
    Démant P; Iványi D
    Nature; 1981 Mar; 290(5802):146-9. PubMed ID: 6163086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of foreign H-2-like antigens by a chemically-induced murine tumour (MCG4).
    Schirrmacher V; Garrido F; Garcia-Olivares F; Perez M; Torres MD
    J Immunogenet; 1980 Feb; 7(1):51-9. PubMed ID: 7373066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular heterogeneity of H-2 antigens.
    Démant P; Iványi D; Oudshoorn-Snoek M; Calafat J; Roos MH
    Immunol Rev; 1981; 60():5-22. PubMed ID: 6171504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. III. Reactivity of certain anti-H-2.28 alloantisera with Qa-2 antigen.
    Iványi D; Cherry M; Démant P
    Immunogenetics; 1982; 15(5):477-84. PubMed ID: 6179861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of H-2Db antigens implies haplotype differences in the number of H-2 molecules expressed.
    Melino MR; Nichols EA; Strausser HR; Hansen TH
    J Immunol; 1982 Jul; 129(1):222-6. PubMed ID: 6177750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public H-2 specificities are target determinants for alloreactive cytotoxic T lymphocytes.
    Vazquez A; Senik A; Fridman WH; Neauport-Sautes C
    J Immunogenet; 1980 Feb; 7(1):107-22. PubMed ID: 6154748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Private specificity of H-2Ldx molecule detected serologically by a surface antigen redistribution method (capping).
    Ivány D; Démant P
    Tissue Antigens; 1982 Oct; 20(4):274-81. PubMed ID: 6183786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of shared H-2Kk and H-2Dk antigens that function as self determinants for cell-mediated lympholysis to trinitrophenyl-self.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1522-5. PubMed ID: 6162891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural definition of a family of Ld-like molecules distributed among four of seven haplotypes compared.
    Lillehoj EP; Myers NB; Lee DR; Hansen TH; Coligan JE
    J Immunol; 1985 Aug; 135(2):1271-5. PubMed ID: 3925005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of private H-2 and Ia specificities of H-2r haplotype.
    Beisel KW; Lafuse WP; Stimpfling JH; David CS
    Immunogenetics; 1981; 12(1-2):191-7. PubMed ID: 6162793
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
    Forman J; Goodenow RS; Hood L; Ciavarra R
    J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis.
    Koeller D; Lieberman R; Miyazaki J; Appella E; Ozato K; Mann DW; Forman J
    J Exp Med; 1987 Sep; 166(3):744-60. PubMed ID: 2442290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative and quantitative aspects of anti-H-2Ld sera.
    Oudshoorn-Snoek M; Iványi D; Démant P
    Transplantation; 1981 Aug; 32(2):128-36. PubMed ID: 7292590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
    Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular localization of allogeneic and self determinants recognized by bulk and clonal populations of cytotoxic T cells.
    Levy RB; Ozato K; Richardson JC; Bluestone JA
    J Immunol; 1985 Feb; 134(2):677-83. PubMed ID: 2578159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias.
    Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H
    J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.